Generic Medicine Info
History of blood disorders. Active liver disease or history of hepatic impairment.
Special Precautions
Avoid abrupt withdrawal. Renal impairment. Childn. Pregnancy and lactation. Patient Counselling Avoid exposure to UV radiation. Monitoring Parameters Perform CBC and LFT prior to and during treatment. Monitor for suicidality (e.g. depression, suicidal thoughts, mood/behavioural changes).
Adverse Reactions
Nervous: Headache, dizziness, anorexia, insomnia, somnolence, anxiety. GI: Nausea, vomiting, dyspepsia, constipation or diarrhoea. Resp: Upper resp tract infection, rhinitis. Hepatic: Increased SGPT. Genitourinary: UTI, intramenstrual bleeding. Ophthalmologic: Diplopia. Otic:Otitis media. Dermatologic: Photosensitivity, acne, rash, facial oedema. Others: Fatigue, decreased wt, hypophosphataemia.
Potentially Fatal: Acute hepatic failure, aplastic anaemia.
Drug Interactions
Enhanced metabolism w/ enzyme inducers (e.g. phenobarbital, carbamazepine, phenytoin). Prolonged half-life w/ gabapentin.
CIMS Class
ATC Classification
N03AX10 - felbamate ; Belongs to the class of other antiepileptics.
Disclaimer: This information is independently developed by CIMS based on felbamate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in